Nayana Somesh

Nayana Somesh

Auto-generated profile, based on publicly available information

Nayana Somesh

Department of Life Sciences, CHRIST (Deemed to be University), Bengaluru, 560029, Karnataka, India

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Progress in Nanoscience and Nanotechnology
Verified
Journal Article
Closed access
PDF file
KJKrishna Joshi
Krishna Joshi
SKSriya Kotha
Sriya Kotha
NSNayana Somesh
Nayana Somesh
HHHemanth Hinnakki
Hemanth Hinnakki
TBThejaswi Bhandary
Thejaswi Bhandary
KPKuppusamy Alagesan Paari
Kuppusamy Alagesan Paari
Conventional cancer treatment methods, such as chemotherapy and radiation, lack specificity and primarily affect surrounding healthy cells. Therefore, a therapy that specifically targets and kills cancerous cells, leading to their apoptosis, could enhance the effectiveness of cancer treatment. Plant-mediated nanoparticles offer a promising solution. Plant phytochemicals act as safe, non-toxic reducing and stabilizing agents, providing an eco-friendly approach for drug delivery, detection, and imaging. Both inorganic (gold and silver) and organic (liposomes and dendrimers) nanoparticles are utilized for active and passive targeted delivery systems. These nanomedicines selectively accumulate therapeutic molecules in tumor tissues while reducing systemic toxicity, which can promote the inhibition of angiogenesis, the induction of mitochondrial damage, and the targeted generation of Reactive Oxygen Species (ROS). Existing reviews rarely systematically integrate green synthesis methodologies, multi-type delivery carriers, and translational challenges. This review discusses the natural variability, agglomeration, and bioavailability of therapeutic nanoparticles and provides a novel, unifying perspective on the multi-component synergy of plant extracts, demonstrating the role of complex bioactive mixtures and nanocarriers in overcoming current limitations in clinical translation and single-compound therapies against the tumor microenvironment.